Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05174507
What this trial is testing

Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes

Who this might be right for
Postprandial Hypoglycemia
University Hospital, Basel, Switzerland
Early research (Phase 1)Looking for participantsNCT07172971
What this trial is testing

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Vanderbilt University Medical Center 10
Post-approval studies (Phase 4)Looking for participantsNCT07572032
What this trial is testing

Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

Who this might be right for
Heart Failure Due to Coronary Artery DiseaseValvular CardiomyopathyHeart Failure
Kyungsub Song 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT07342764
What this trial is testing

Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)Antipsychotic-induced Weight Gain
Sultan Qaboos University 110
Large-scale testing (Phase 3)Looking for participantsNCT07056699
What this trial is testing

SGLT2i, Pioglitazone, and Ketone Production in T1D

Who this might be right for
Type1diabetes
The University of Texas Health Science Center at San Antonio 24
Not applicableStudy completedNCT05795400
What this trial is testing

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection Fraction+1 more
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Post-approval studies (Phase 4)Study completedNCT05152940
What this trial is testing

ERTU-SODIUM: Study on the Effects of Ertugliflozin on Sodium Storage, Interstitial Volume, and Plasma Volume in HFrEF

Who this might be right for
Heart Failure With Reduced Ejection FractionCongestion
Icahn School of Medicine at Mount Sinai 28
Post-approval studies (Phase 4)Ended earlyNCT05737186
What this trial is testing

SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency

Who this might be right for
Heart Failure With Reduced Ejection FractionRenal Insufficiency, Chronic
Peking University People's Hospital 11
Not applicableNot Yet RecruitingNCT07392788
What this trial is testing

Early Gliflozin for Elderly Patients With Acute Decompensated Heart Failure in the Emergency Department

Who this might be right for
Acute Heart Failure (AHF)
Centre Hospitalier Universitaire de Besancon 144
Large-scale testing (Phase 3)Study completedNCT04304261
What this trial is testing

Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)

Who this might be right for
Diabetes Mellitus, Type 2Cognitive Functions Confusion
Third Military Medical University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07225465
What this trial is testing

Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin

Who this might be right for
Type 1 Diabetes Mellitus
St Vincent's Hospital Melbourne 115
Early research (Phase 1)Looking for participantsNCT07053319
What this trial is testing

SGLT2i, Pioglitazone, and Ketone Production in T2D

Who this might be right for
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio 64
Testing effectiveness (Phase 2)Study completedNCT03128528
What this trial is testing

Analysing the Effect of Empagliflozin on Reduction of Tissue Sodium Content in Patients With Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
University of Erlangen-Nürnberg Medical School 84
Large-scale testing (Phase 3)Study completedNCT07591077
What this trial is testing

SGLT2 Adjunct in T1D

Who this might be right for
Type 1 DiabetesNephropathy, Diabetic
Ain Shams University 86
Not applicableNot Yet RecruitingNCT07708610
What this trial is testing

Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes

Who this might be right for
PneumoniaType 2 Diabetes Mellitus (T2DM)
Chung Shan Medical University 71,775
Not applicableLooking for participantsNCT07491042
What this trial is testing

Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.

Who this might be right for
End Stage Chronic Renal Failure
Oman Ministry of Health 38
Large-scale testing (Phase 3)Study completedNCT02635386
What this trial is testing

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Who this might be right for
Polycystic Ovary SyndromeObesity
Woman's 119
Not applicableStudy completedNCT03200782
What this trial is testing

Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study

Who this might be right for
Postprandial HypoglycemiaBariatric SurgeryLate Dumping Syndrome
University Hospital, Basel, Switzerland 12
Post-approval studies (Phase 4)Looking for participantsNCT06562582
What this trial is testing

STunning in Acute Myocardial Infarction - BAS

Who this might be right for
Myocardial Infarct
Vastra Gotaland Region 120
Early research (Phase 1)Study completedNCT00963768
What this trial is testing

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 116
Next Page